127 related articles for article (PubMed ID: 1398512)
1. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract][Full Text] [Related]
3. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
4. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
Miller TP; Grogan TM; Dahlberg S; Spier CM; Braziel RM; Banks PM; Foucar K; Kjeldsberg CR; Levy N; Nathwani BN
Blood; 1994 Mar; 83(6):1460-6. PubMed ID: 8123837
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
9. Relevance of Ki-67 expression in the classification of non-Hodgkin's lymphomas: a morphometric and double-immunostaining study.
Houmand A; Abrahamsen B; Tinggaard Pedersen N
Histopathology; 1992 Jan; 20(1):13-20. PubMed ID: 1737622
[TBL] [Abstract][Full Text] [Related]
10. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
[TBL] [Abstract][Full Text] [Related]
12. Growth fraction in non-Hodgkin's lymphomas and reactive lymphadenitis determined by Ki-67 monoclonal antibody in fine-needle aspirates.
Skoog L; Tani E; Svedmyr E; Johansson B
Diagn Cytopathol; 1995 May; 12(3):234-8; discussion 238-40. PubMed ID: 7621718
[TBL] [Abstract][Full Text] [Related]
13. Distribution and characterization of follicular dendritic cells (FDCs) in non-Hodgkin's lymphomas.
Suzuki S; Nakamura N; Abe M; Wakasa H
Adv Exp Med Biol; 1995; 378():297-9. PubMed ID: 8526077
[No Abstract] [Full Text] [Related]
14. Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody.
Weiss LM; Strickler JG; Medeiros LJ; Gerdes J; Stein H; Warnke RA
Hum Pathol; 1987 Nov; 18(11):1155-9. PubMed ID: 3679189
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases.
Abbondanzo SL; Wenig BM
Cancer; 1995 Mar; 75(6):1281-91. PubMed ID: 7882278
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.
Schwartz BR; Pinkus G; Bacus S; Toder M; Weinberg DS
Am J Pathol; 1989 Feb; 134(2):327-36. PubMed ID: 2464940
[TBL] [Abstract][Full Text] [Related]
17. Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections. Comparison of the performance characteristics of four commercially available antibody preparations.
Kurtin PJ; Roche PC
Am J Surg Pathol; 1993 Sep; 17(9):898-904. PubMed ID: 8352374
[TBL] [Abstract][Full Text] [Related]
18. c-myc mRNA expression in non-Hodgkin's lymphomas.
Fellbaum C; Radaszkiewicz T; Ruhri C; Pütz B; Lehmacher W; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):61-8. PubMed ID: 1352077
[TBL] [Abstract][Full Text] [Related]
19. Expression of classical protein kinase C subspecies in non-neoplastic lymphocytes and non-Hodgkin's lymphomas: an immunohistochemical study.
Hojo H; Morimura Y; Abe M; Wakasa H
Pathol Int; 1996 Feb; 46(2):148-54. PubMed ID: 10846563
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
